ArielAnnNelsonMD

Physician

Dr. Nelson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9200 W Wisconsin Ave
# Clcc
Milwaukee, WI 53226
Phone+1 414-805-0509

Fax+1 414-805-6808

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2013 - 2016
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2013

PubMed

76 citations
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Mehmet Asim Bilen, Victor Sacristan Santos
Cancer. 2020-03-15
36 citations
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria
European Urology Oncology. 2021-06-01
25 citations
Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer
Ariel Ann Nelson, Alexandra M. Harrington, Steven H. Kroft, M A Dahar, Mehdi Hamadani
Bone Marrow Transplantation. 2016-02-01

Lectures

Phase II study of eribulin mesylate for treatment of CNS metastases (mets) in metastatic breast cancer (mBC).
2019 ASCO Annual Meeting - 6/1/2019
Association of early bone metastases and outcomes of the bone predominant metastatic urothelial carcinoma (BP mUC) phenotype.
2019 ASCO Annual Meeting - 6/1/2019